Literature DB >> 22350414

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.

Pingyu Zhang1, Katelynn Bill, Juehui Liu, Eric Young, Tingsheng Peng, Svetlana Bolshakov, Aviad Hoffman, Yechun Song, Elizabeth G Demicco, Dolores Lopez Terrada, Chad J Creighton, Matthew L Anderson, Alexander J Lazar, George G Calin, Raphael E Pollock, Dina Lev.   

Abstract

Liposarcoma can be an aggressive, debilitating, and fatal malignancy. In this study, we identifed miRNAs associated with the differentiation status of liposarcoma to gain insight into the basis for its progression. miRNA expression profiles determined in human tumors and normal fat specimens identified a dedifferentiated tumor expression signature consisting of 35 miRNAs. Deregulated miRNA expression was confirmed in a second independent sample cohort. The miR-155 was the most overexpressed miRNA and functional investigations assigned an important role in the growth of dedifferentiated liposarcoma cell lines. Transient or stable knockdown of miR-155 retarded tumor cell growth, decreased colony formation, and induced G(1)-S cell-cycle arrest in vitro and blocked tumor growth in murine xenografts in vivo. We identified casein kinase 1α (CK1α) as a direct target of miR-155 control which enhanced β-catenin signaling and cyclin D1 expression, promoting tumor cell growth. In summary, our results point to important functions for miR-155 and β-catenin signaling in progression of liposarcoma, revealing mechanistic vulnerabilities that might be exploited for both prognostic and therapeutic purposes. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350414      PMCID: PMC3319789          DOI: 10.1158/0008-5472.CAN-11-3027

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

1.  CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.

Authors:  Robert W Georgantas; Richard Hildreth; Sebastien Morisot; Jonathan Alder; Chang-gong Liu; Shelly Heimfeld; George A Calin; Carlo M Croce; Curt I Civin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-09       Impact factor: 11.205

2.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.

Authors:  Margaret S Ebert; Joel R Neilson; Phillip A Sharp
Journal:  Nat Methods       Date:  2007-08-12       Impact factor: 28.547

3.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

Authors:  Stefan Costinean; Nicola Zanesi; Yuri Pekarsky; Esmerina Tili; Stefano Volinia; Nyla Heerema; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

Review 4.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

5.  Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.

Authors:  Stacy Ugras; Elliott Brill; Anders Jacobsen; Markus Hafner; Nicholas D Socci; Penelope L Decarolis; Raya Khanin; Rachael O'Connor; Aleksandra Mihailovic; Barry S Taylor; Robert Sheridan; Jeffrey M Gimble; Agnes Viale; Aimee Crago; Cristina R Antonescu; Chris Sander; Thomas Tuschl; Samuel Singer
Journal:  Cancer Res       Date:  2011-06-21       Impact factor: 12.701

6.  MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.

Authors:  A E Szafranska; T S Davison; J John; T Cannon; B Sipos; A Maghnouj; E Labourier; S A Hahn
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

7.  MicroRNA expression signature of human sarcomas.

Authors:  S Subramanian; W O Lui; C H Lee; I Espinosa; T O Nielsen; M C Heinrich; C L Corless; A Z Fire; M van de Rijn
Journal:  Oncogene       Date:  2007-10-08       Impact factor: 9.867

8.  Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Authors:  Meritxell Gironella; Mylène Seux; Min-Jue Xie; Carla Cano; Richard Tomasini; Julien Gommeaux; Stephane Garcia; Jonathan Nowak; Man Lung Yeung; Kuan-Teh Jeang; Amandine Chaix; Ladan Fazli; Yoshiharu Motoo; Qing Wang; Palma Rocchi; Antonio Russo; Martin Gleave; Jean-Charles Dagorn; Juan L Iovanna; Alice Carrier; Marie-Josèphe Pébusque; Nelson J Dusetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

9.  miRGen: a database for the study of animal microRNA genomic organization and function.

Authors:  Molly Megraw; Praveen Sethupathy; Benoit Corda; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2006-11-15       Impact factor: 16.971

10.  Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder.

Authors:  Ryan M O'Connell; Dinesh S Rao; Aadel A Chaudhuri; Mark P Boldin; Konstantin D Taganov; John Nicoll; Ronald L Paquette; David Baltimore
Journal:  J Exp Med       Date:  2008-02-25       Impact factor: 14.307

View more
  51 in total

1.  Extensive survey of STAT6 expression in a large series of mesenchymal tumors.

Authors:  Elizabeth G Demicco; Paul W Harms; Rajiv M Patel; Steven C Smith; Davis Ingram; Keila Torres; Shannon L Carskadon; Sandra Camelo-Piragua; Jonathan B McHugh; Javed Siddiqui; Nallasivam Palanisamy; David R Lucas; Alexander J Lazar; Wei-Lien Wang
Journal:  Am J Clin Pathol       Date:  2015-05       Impact factor: 2.493

Review 2.  microRNA regulation of Wnt signaling pathways in development and disease.

Authors:  Jia L Song; Priya Nigam; Senel S Tektas; Erica Selva
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

Review 3.  Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.

Authors:  Amir Abbas Momtazi; Giuseppe Derosa; Pamela Maffioli; Maciej Banach; Amirhossein Sahebkar
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

4.  MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.

Authors:  Junfeng Wang; Fang Yu; Xuemei Jia; Stephen Iwanowycz; Yuzhen Wang; Shiang Huang; Walden Ai; Daping Fan
Journal:  Int J Cancer       Date:  2014-08-30       Impact factor: 7.396

5.  Demethylation of microRNA-142 induced by demethylation agents plays a suppressive role in osteosarcoma cells.

Authors:  Muliang Ding; Jianzhong Hu; Jiangdong Ni; Zhonghui Zheng; Deye Song; Junjie Wang
Journal:  Oncol Lett       Date:  2015-03-13       Impact factor: 2.967

6.  Epigenetic Regulators: New Therapeutic Targets for Soft Tissue Sarcoma.

Authors:  Pingyu Zhang; Raphael E Pollock
Journal:  Cancer Cell Microenviron       Date:  2014

Review 7.  Inflammatory stress and sarcomagenesis: a vicious interplay.

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2013-08-27       Impact factor: 3.667

Review 8.  Molecular basis of the irritable bowel syndrome.

Authors:  Anna Vaiopoulou; Georgios Karamanolis; Theodora Psaltopoulou; George Karatzias; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Plasma levels of miRNA-155 as a powerful diagnostic marker for dedifferentiated liposarcoma.

Authors:  Aleksandar Boro; David Bauer; Walter Born; Bruno Fuchs
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

10.  Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein.

Authors:  Columba de la Parra; Linette Castillo-Pichardo; Ailed Cruz-Collazo; Luis Cubano; Roxana Redis; George A Calin; Suranganie Dharmawardhane
Journal:  Nutr Cancer       Date:  2016-01-15       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.